Twitxy Saved

Jon Cohen

@sciencecohen

Science magazine staff writer on infectious diseases, outbreaks, immunology, vaccines, global health, genomics, CRISPR, surfing. Views mine. @joncohen@mas.to
Cardiff, California joncohen.org Joined April 2009
1.4K Following 37K Followers 3.7K Posts

Latest posts 5

Jon Cohen @sciencecohen
Ask @SetteLab. I'm not aware of any compelling evidence that SARS-CoV-2 depletion of T or B cells has any significant, longterm impact on the immune system's ability to replace them. SRCV2 doesn't target immune cells, and it's not HIV.
@thilogross @manlius84 @DirkBrockmann @sciencecohen and/or @angie_rasmussen might know if there's any evidence for this.
View quoted post on X
Jon Cohen @sciencecohen
As story explains, this isn't all-or-nothing phenomenon.

“I think of interference as a small push,” says Aubree Gordon....“It depends on population immunity and when that virus last circulated and flu and COVID vaccination rates.”

But interference is a real phenomenon.
Henrik @HenrikAborym Nov 25, 2022
@Ivriniel @OrangeInvasion @Aaron_Derfel @EricTopol @ScienceMagazine @sciencecohen @CovidEcoles Yep. México City just hosted a 100k pple music fest during 3 consecutive days. And the reports of respiratory symptons are flooding twitter.

Here is a coinfection (Influenzavirus + COVID) that emerged from there.
View quoted post on X
Jon Cohen @sciencecohen
This paper has fascinating details and carefully documents how recombination happens in individual bats. The SARS-CoV/SARS-CoV-2 mash up, BtSY2, is gulp inducing.
Dr. Angela Rasmussen Verified account @angie_rasmussen Nov 24, 2022
This Thanksgiving, I’m grateful for scientists like Mang Shi & colleagues, who do great work despite many challenges.

Here they found a novel recombinant bat CoV that is very similar to SARS-CoV-2 in its receptor binding domain.

In nature, not a lab.

biorxiv.org/content/10.110…
View quoted post on X